Claire L. Faulkner
Bristol, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Defining the recommended gray zone in O6-methylguanine-DNA methyltransferase promoter methylation pyrosequencing reporting: A robust, translatable method to implement new EANO guidelines.
Journal: Neuro-oncology advances
Published: May 30, 2025
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.
Journal: The Cochrane database of systematic reviews
Published: March 02, 2022
MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review.
Journal: Neuro-oncology
Published: September 01, 2021
Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta-analysis based on a Cochrane systematic review.
Journal: Neuropathology and applied neurobiology
Published: May 11, 2021
Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide.
Journal: The Cochrane database of systematic reviews
Published: March 12, 2021
Next-generation sequencing demonstrates the rarity of short kinase variants specific to quadruple wild-type gastrointestinal stromal tumours.
Journal: Journal of clinical pathology
Published: April 01, 2020
EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma.
Journal: Oncogene
Published: October 02, 2019
Defective DNA Polymerase α-Primase Leads to X-Linked Intellectual Disability Associated with Severe Growth Retardation, Microcephaly, and Hypogonadism.
Journal: American journal of human genetics
Published: December 08, 2018
Evaluation of the quality of RNA extracted from archival FFPE glioblastoma and epilepsy surgical samples for gene expression assays.
Journal: Journal of clinical pathology
Published: December 16, 2017
BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum.
Journal: Journal of neuropathology and experimental neurology
Published: July 30, 2015
Current Understanding of BRAF Alterations in Diagnosis, Prognosis, and Therapeutic Targeting in Pediatric Low-Grade Gliomas.
Journal: Frontiers in oncology
Published: December 17, 2014
EGFR and EGFRvIII analysis in glioblastoma as therapeutic biomarkers.
Journal: British journal of neurosurgery
Published: August 21, 2014
Last Updated: 09/26/2026